[Federal Register: December 5, 2008 (Volume 73, Number 235)]
[Notices]
[Page 74195]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05de08-102]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
registration under 21 U.S.C. 952(a)(2) authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal Regulations
(CFR), 1301.34(a), this is notice that on October 6, 2008, Tocris
Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri
63021-4500, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as an importer of the basic
classes of controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Amphetamine (1100).......................... II
Phencyclidine (7471)........................ II
Cocaine (9041).............................. II
Diprenorphine (9058)........................ II
------------------------------------------------------------------------
The company plans to import the above listed controlled substances
for non-clinical laboratory based research only.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43 and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed
no later than January 5, 2009.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e), and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745-46), all applicants for
registration to import basic classes of any controlled substances in
schedules I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b),(c),(d),(e), and (f) are satisfied.
Dated: November 26, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-28748 Filed 12-4-08; 8:45 am]
BILLING CODE 4410-09-P